No abstract available
MeSH terms
-
Antineoplastic Agents / therapeutic use*
-
Disease-Free Survival
-
Female
-
Humans
-
Male
-
Molecular Targeted Therapy / methods
-
Mutation
-
Neoplasms / drug therapy*
-
Neoplasms / genetics*
-
Neoplasms / mortality
-
Patient Safety
-
Quinuclidines / therapeutic use*
-
Risk Assessment
-
Sensitivity and Specificity
-
Signal Transduction / drug effects
-
Survival Analysis
-
Treatment Outcome
-
Tumor Suppressor Protein p53 / drug effects*
-
Tumor Suppressor Protein p53 / genetics*
Substances
-
Antineoplastic Agents
-
Quinuclidines
-
Tumor Suppressor Protein p53
-
eprenetapopt